162 related articles for article (PubMed ID: 15677712)
1. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
Yoshikawa N; Yamamoto K; Shimizu N; Yamada S; Morimoto C; Tanaka H
Mol Endocrinol; 2005 May; 19(5):1110-24. PubMed ID: 15677712
[TBL] [Abstract][Full Text] [Related]
2. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor.
Yoshikawa N; Makino Y; Okamoto K; Morimoto C; Makino I; Tanaka H
J Biol Chem; 2002 Feb; 277(7):5529-40. PubMed ID: 11741935
[TBL] [Abstract][Full Text] [Related]
3. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.
Yoshikawa N; Nagasaki M; Sano M; Tokudome S; Ueno K; Shimizu N; Imoto S; Miyano S; Suematsu M; Fukuda K; Morimoto C; Tanaka H
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1363-73. PubMed ID: 19293335
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
5. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
[TBL] [Abstract][Full Text] [Related]
6. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
Tao YG; Xu Y; Xu HE; Simons SS
Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
[TBL] [Abstract][Full Text] [Related]
7. Two glucocorticoid binding sites on the human glucocorticoid receptor.
Srivastava D; Thompson EB
Endocrinology; 1990 Oct; 127(4):1770-8. PubMed ID: 2205477
[TBL] [Abstract][Full Text] [Related]
8. Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
Cho S; Blackford JA; Simons SS
Biochemistry; 2005 Mar; 44(9):3547-61. PubMed ID: 15736964
[TBL] [Abstract][Full Text] [Related]
9. First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain-Peroxisome Proliferator-Activated
Liu X; Wang Y; Ortlund EA
Mol Pharmacol; 2019 Oct; 96(4):408-417. PubMed ID: 31391291
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
[TBL] [Abstract][Full Text] [Related]
11. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
Kroe RR; Baker MA; Brown MP; Farrow NA; Gautschi E; Hopkins JL; LaFrance RR; Kronkaitis A; Freeman D; Thomson D; Nabozny G; Grygon CA; Labadia ME
Biophys Chem; 2007 Jul; 128(2-3):156-64. PubMed ID: 17466438
[TBL] [Abstract][Full Text] [Related]
12. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
Dey R; Roychowdhury P
J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
[TBL] [Abstract][Full Text] [Related]
14. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
[TBL] [Abstract][Full Text] [Related]
15. [3H]cortivazol: a unique high affinity ligand for the glucocorticoid receptor.
Schlechte JA; Simons SS; Lewis DA; Thompson EB
Endocrinology; 1985 Oct; 117(4):1355-62. PubMed ID: 4029081
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
Miller AL; Webb MS; Thompson EB
Steroids; 2007 Sep; 72(9-10):673-81. PubMed ID: 17606285
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators.
Sharma R; Prichard D; Majer F; Byrne AM; Kelleher D; Long A; Gilmer JF
J Med Chem; 2011 Jan; 54(1):122-30. PubMed ID: 21158453
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
Stevens A; Garside H; Berry A; Waters C; White A; Ray D
Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
[TBL] [Abstract][Full Text] [Related]
19. A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation.
Dezitter X; Fagart J; Taront S; Fay M; Masselot B; Hétuin D; Formstecher P; Rafestin-Oblin ME; Idziorek T
Mol Pharmacol; 2014 Feb; 85(2):226-36. PubMed ID: 24225022
[TBL] [Abstract][Full Text] [Related]
20. Optical probes to identify the glucocorticoid receptor ligands in living cells.
Awais M; Sato M; Umezawa Y
Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
